The American Feed Industry Association's legal counsel told FDA that the agency lacks the legal authority to require new animal drug sponsors to report species-specific distribution estimates and such collection would not result in useful data anyway. The Animal Health Institute additionally expressed concerns that asking for species sales estimates will force companies to provide "best guesses." Simultaneously, a myriad of advocacy and consumer groups expressed support for the proposed data collection, and urged the agency to publicly report as...